全髋关节置换术后假体周围感染对社会经济的长期影响如何?一项马尔可夫分析
该研究构建状态转换马尔可夫模型,从社会视角估算55、60、65岁假设工作年龄患者全髋关节置换术后假体周围感染的终生直接与间接成本。模型发现65岁患者基础病例成本为390806美元,间接成本随感染时年龄降低而显著增加。作者结论认为计入治疗失败率与间接成本后,总体社会成本远高于既往估计,需进一步研究比较替代治疗路径的临床与经济效果。
要点
- 65岁患者全髋关节置换术后假体周围感染的终生社会成本基础病例为390806美元。
- 55岁患者再感染率12%时成本达474004美元,年龄越低间接成本占比越大。
- 作者认为计入失败率与间接成本后总体治疗成本远高于既往估计。
核心结论
- 计入当前治疗方案的相当失败率与间接成本后,全髋关节置换术后假体周围感染的总体社会治疗成本远高于既往估计。
- 这些总体成本结合全髋关节置换术预计大幅增加与感染性失败率稳定状态,在考虑全髋关节置换术总成本时应予以纳入。
- 需要进一步研究以充分比较替代治疗路径的临床与经济效果。
研究设计与样本
- 研究构建状态转换马尔可夫模型,健康状态按手术治疗选项定义,包括清创灌洗并模块更换、单阶段翻修和两阶段翻修。
- 再手术率归因于感染性与无菌性失败模式,直接与间接成本为通过多篇同行评议骨科与感染病期刊的系统综述及医疗保险报销数据计算所得的估算值。
- 分析从社会视角覆盖假设患者终生,成本按每年3%贴现,并开展敏感性分析以刻画输入变量不确定性的影响。
- 研究设定三个假设工作年龄场景:55岁、60岁和65岁。
- 证据等级为II级,经济学与决策分析。
主要发现
- 模型发现65岁感染全髋关节置换术患者的基础病例成本为390806美元。
- 单因素敏感性分析给出成本范围为389307美元(65岁、再感染率3%)至474004美元(55岁、再感染率12%)。
- 间接成本如损失工资占成本的相当部分,且随感染时年龄降低而显著增加。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文结论指出需要进一步研究以充分比较替代治疗路径的临床与经济效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current estimates for the direct costs of a single episode of care for periprosthetic joint infection (PJI) after THA are approximately USD 100,000. These estimates do not account for the costs of failed treatments and do not include indirect costs such as lost wages. QUESTIONS/PURPOSES: The goal of this study was to estimate the long-term economic effect to society (direct and indirect costs) of a PJI after THA treated with contemporary standards of care in a hypothetical patient of working age (three scenarios, age 55, 60, and 65 years). METHODS: We created a state-transition Markov model with health states defined by surgical treatment options including irrigation and débridement with modular exchange, single-stage revision, and two-stage revision. Reoperation rates attributable to septic and aseptic failure modes and indirect and direct costs were calculated estimates garnered via multiple systematic reviews of peer-reviewed orthopaedic and infectious disease journals and Medicare reimbursement data. We conducted an analysis over a hypothetical patient's lifetime from the societal perspective with costs discounted by 3% annually. We conducted sensitivity analysis to delineate the effects of uncertainty attributable to input variables. RESULTS: The model found a base case cost of USD 390,806 per 65-year-old patient with an infected THA. One-way sensitivity analysis gives a range of USD 389,307 (65-year-old with a 3% reinfection rate) and USD 474,004 (55-year-old with a 12% reinfection rate). Indirect costs such as lost wages make up a considerable portion of the costs and increase considerably as age at the time of infection decreases. CONCLUSIONS: The results of this study show that the overall treatment of a periprosthetic infection after a THA is markedly more expensive to society than previously estimated when accounting for the considerable failure rates of current treatment options and including indirect costs. These overall costs, combined with a large projected increase in THAs and a steady state of septic failures, should be taken into account when considering the total cost of THA. Further research is needed to adequately compare the clinical and economic effectiveness of alternative treatment pathways. LEVEL OF EVIDENCE: Level II, economic and decision analysis.
引用
- Parisi TJ, Konopka JF, Bedair HS, et al. What is the Long-term Economic Societal Effect of Periprosthetic Infections After THA? A Markov Analysis. Clin Orthop Relat Res. 2017. PMID: 28389865. doi:10.1007/s11999-017-5333-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。